Analysts have maintained their price target for Tactile Systems Technology at $23.50. They cite the company's leading positions in key device markets and an improved outlook following recent strategic adjustments.
Analyst Commentary
Following recent coverage initiations, market observers have weighed both the strengths and challenges facing Tactile Systems Technology, particularly in light of its positioning within the device market and strategic adjustments.
Bullish Takeaways
- Bullish analysts highlight the company’s leading share in pneumatic compression devices for lower extremity conditions, reflecting a strong competitive advantage.
- Strong demand potential is noted, with approximately 15 to 25 million patients in the U.S. affected by lymphedema or bronchiectasis. However, only a minority have been diagnosed so far.
- Recent operational and strategic optimizations are viewed as setting the company up for renewed growth acceleration by 2026.
- Resolution of coverage headwinds improves near-term execution prospects and supports the current valuation targets.
Bearish Takeaways
- Bears caution that the relatively low rate of diagnosed patients in target populations may challenge short-term growth conversion.
- While market share positions are strong, competition and potential reimbursement pressures could impact future margins or topline growth.
- There is some uncertainty around the timeline and sustainability of the projected 2026 growth acceleration given market and regulatory dynamics.
What's in the News
- Tactile Systems Technology updated its 2025 earnings guidance, now projecting total revenue between $310 million and $315 million. This is an increase from the previous 2024 figure of $293.0 million, and implies year-over-year growth of roughly 6% to 8% (Key Developments).
- Between April 1, 2025 and June 24, 2025, the company repurchased 1,507,496 shares for $16.42 million, completing the planned buyback of 2,338,617 shares totaling $30 million. This buyback was part of a program announced on November 4, 2024 (Key Developments).
Valuation Changes
- Fair Value: Remained unchanged at $16.83.
- Discount Rate: Increased slightly from 7.64% to 7.66%.
- Revenue Growth: Remained effectively stable at 9.19%.
- Net Profit Margin: Maintained at 9.44%.
- Future P/E: Rose marginally from 9.72x to 9.72x.
Have other thoughts on Tactile Systems Technology?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.